跳至主要内容
临床试验/NCT04779905
NCT04779905已完成不适用

Assessment of Chronic Kidney Disease in Non Alcoholic Fatty Liver Disease(NAFLD) Patients

Sohag University1 个研究点 分布在 1 个国家目标入组 62 人开始时间: 2021年2月28日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
62
试验地点
1
主要终点
prevalence of chronic kidney disease in nafld patient

研究概览

简要总结

Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease worldwide. This disease reportedly affects up to 30% of the general population in Western countries, especially in patients with metabolic syndrome, obesity, and type II diabetes. NAFLD is considered to be an independent risk factor for cardiovascular disease and there is accumulating evidence to support a causative role in the development of chronic kidney disease (CKD). So, we aim first to assess the prevalence of chronic kidney disease in NAFLD patients, secondly to detect the association between hepatic fibrosis and CKD in NAFLD patients

详细描述

This study will be conducted on 100 patients 70 patients diagnosed to has NAFLD by ultrasonography presented to the outpatient clinic of Sohag University Hospital, and A control group of 30 healthy volunteers who looks normal on ultrasonography from February 2021 to July 2021.

Methods:

All included patients will be subjected to:

  1. Detailed history, complete general and systemic examination .
  2. BMI will be calculated as follow
  3. Abdominal Ultrasonography.
  4. Laboratory investigations:

Fasting and post-prandial blood sugar Serum lipogram. Liver function tests. Serum creatinine, Albumin -creatinine Ratio. 5. Calculation of estimated Glomerular Filtration Rate eGFR. 6. Liver stiffness measurements to detect degree of fibrosis and measurement of the degree of steatosis using (Fibroscan)

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Cross Sectional

入排标准

年龄范围
20 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients diagnosed to has NAFLD by ultrasonography presented to the outpatient clinic of Sohag University Hospital

排除标准

  • Diabetic patients.
  • Hypertensive patients.
  • Other causes of chronic liver disease rather than NAFLD.

结局指标

主要结局

prevalence of chronic kidney disease in nafld patient

时间窗: February 2021 to July 2021

correlation of chronic kidney disease and degree of hepatic fibrosis in nafld patient

时间窗: February 2021 to July 2021

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mona Mohammed Abdelrhman

Principal investigator

Sohag University

研究点 (1)

Loading locations...

相似试验